Depression Archives - Page 4 of 6 - PsychPartners

CBT Helps Sustain Esketamine

Depression Difficult to Treat Depression Ketamine Research Therapy Top Research

CBT Helps Sustain Esketamine

May 7, 2026by Chris Aiken, MD0

Esketamine Over Five Years: Real World Data

Depression Difficult to Treat Depression Ketamine Medications Research

Esketamine Over Five Years: Real World Data

May 3, 2026by Chris Aiken, MD0

Large Trial Tests Probiotic in Depression

Depression Research Supplements

Large Trial Tests Probiotic in Depression

May 2, 2026by Chris Aiken, MD0

Hormones for Menopausal Depression

Depression Research Research for the Public Women's Health

Hormones for Menopausal Depression

May 2, 2026by Chris Aiken, MD0

Psilocybin in Treatment Resistant Depression

Depression Difficult to Treat Depression Medications Psychedelics Research Top Research

Psilocybin in Treatment Resistant Depression

May 1, 2026by Chris Aiken, MD0

Semaglutide May Improve Persistence in Depression

Depression GLP1 Agonists Research

Semaglutide May Improve Persistence in Depression

May 1, 2026by Chris Aiken, MD0

Lithium, Quetiapine, or Esketamine in Treatment-Resistant Depression?

Antidepressants Depression Difficult to Treat Depression Lithium Medications Research

Lithium, Quetiapine, or Esketamine in Treatment-Resistant Depression?

May 1, 2026by Chris Aiken, MD0

Should Therapy Target Positive or Negative Emotions?

Anxiety Depression Research Therapy

Should Therapy Target Positive or Negative Emotions?

April 28, 2026by Chris Aiken, MD0

FDA Approves At-Home tDCS — But Should It Have?

Depression Neuromodulation/TMS Research

FDA Approves At-Home tDCS — But Should It Have?

April 25, 2026by Chris Aiken, MD2

Trazodone Outperforms SSRIs? Depends Who’s Watching.

Antidepressants Depression Research

Trazodone Outperforms SSRIs? Depends Who’s Watching.

April 24, 2026by Chris Aiken, MD0

Ketamine and Liver Risk: How Worried Should You Be?

Depression Difficult to Treat Depression Ketamine Medications Side Effects Top Research

Ketamine and Liver Risk: How Worried Should You Be?

April 22, 2026by Chris Aiken, MD0

Intolerance of Uncertainty Predicts Anxiety and Depression

Anxiety Depression Research Research for the Public Therapy

Intolerance of Uncertainty Predicts Anxiety and Depression

April 22, 2026by Chris Aiken, MD0

Probiotics and Mood in 70 Trials

Anxiety Depression Research Research for the Public Supplements

Probiotics and Mood in 70 Trials

April 22, 2026by Chris Aiken, MD0

In the Pipeline for Depression and Sleep

Depression Hypnotics Medications Research Sleep

In the Pipeline for Depression and Sleep

April 7, 2026by Chris Aiken, MD0

A Vitamin D Disappointment?

Depression Lifestyle Nutrition Research Supplements

A Vitamin D Disappointment?

April 6, 2026by Chris Aiken, MD0

tDCS for Treatment-Resistant Depression

Depression Difficult to Treat Depression Research Research for the Public Top Research

tDCS for Treatment-Resistant Depression

April 6, 2026by Chris Aiken, MD0

Benzodiazepines May Blunt Esketamine

Benzodiazepines Depression Difficult to Treat Depression Ketamine Medications Research

Benzodiazepines May Blunt Esketamine

April 6, 2026by Chris Aiken, MD1

Modern Life, Inflammation, and Depression

Depression Exercise Inflammation Med-Psych Nutrition Research

Modern Life, Inflammation, and Depression

April 6, 2026by Chris Aiken, MD2

Paroxetine in Teens

Antidepressants Child Psychiatry Depression Medications Research

Paroxetine in Teens

April 3, 2026by Chris Aiken, MD0

GLP-1 Agonists Improve Well-being, But Not Depression

Depression GLP1 Agonists Medications Research Research for the Public

GLP-1 Agonists Improve Well-being, But Not Depression

April 2, 2026by Chris Aiken, MD0